| Ident. | Authors (with country if any) | Title |
|---|
| 000035 (2020) |
H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine] | [Potential antiviral therapeutics for 2019 Novel Coronavirus]. |
| 000263 (2020) |
Soeren Lukassen [Allemagne] ; Robert Lorenz Chua [Allemagne] ; Timo Trefzer [Allemagne] ; Nicolas C. Kahn [Allemagne] ; Marc A. Schneider [Allemagne] ; Thomas Muley [Allemagne] ; Hauke Winter [Allemagne] ; Michael Meister [Allemagne] ; Carmen Veith [Allemagne] ; Agnes W. Boots [Pays-Bas] ; Bianca P. Hennig [Allemagne] ; Michael Kreuter [Allemagne] ; Christian Conrad [Allemagne] ; Roland Eils [Allemagne] | SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. |
| 000264 (2020) |
Soeren Lukassen [Allemagne] ; Robert Lorenz Chua [Allemagne] ; Timo Trefzer [Allemagne] ; Nicolas C. Kahn [Allemagne] ; Marc A. Schneider [Allemagne] ; Thomas Muley [Allemagne] ; Hauke Winter [Allemagne] ; Michael Meister [Allemagne] ; Carmen Veith [Allemagne] ; Agnes W. Boots [Pays-Bas] ; Bianca P. Hennig [Allemagne] ; Michael Kreuter [Allemagne] ; Christian Conrad [Allemagne] ; Roland Eils [Allemagne] | SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. |
| 000278 (2020) |
Daniel Stadlbauer [États-Unis] ; Fatima Amanat [États-Unis] ; Veronika Chromikova [États-Unis] ; Kaijun Jiang [États-Unis] ; Shirin Strohmeier [États-Unis] ; Guha Asthagiri Arunkumar [États-Unis] ; Jessica Tan [États-Unis] ; Disha Bhavsar [États-Unis] ; Christina Capuano [États-Unis] ; Ericka Kirkpatrick [États-Unis] ; Philip Meade [États-Unis] ; Ruhi Nichalle Brito [États-Unis] ; Catherine Teo [États-Unis] ; Meagan Mcmahon [États-Unis] ; Viviana Simon [États-Unis] ; Florian Krammer [États-Unis] | SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup. |
| 000321 (2020) |
Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie] | Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy |
| 000376 (2020) |
Syed Faraz Ahmed ; Ahmed A. Quadeer ; Matthew R. Mckay [République populaire de Chine] | Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies |
| 000403 (2020) |
Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie] | Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus. |
| 000533 (2020) |
Muh-Yong Yen [Taïwan] ; Jonathan Schwartz [États-Unis] ; Shey-Ying Chen [Taïwan] ; Chwan-Chuen King [Taïwan] ; Guang-Yang Yang [Taïwan] ; Po-Ren Hsueh [Taïwan] | Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts |
| 000541 (2020) |
Shuai Xia [République populaire de Chine] ; Meiqin Liu [République populaire de Chine] ; Chao Wang [République populaire de Chine] ; Wei Xu [République populaire de Chine] ; Qiaoshuai Lan [République populaire de Chine] ; Siliang Feng [République populaire de Chine] ; Feifei Qi [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Lanying Du [États-Unis] ; Shuwen Liu [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Fei Sun [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Lu Lu [République populaire de Chine] | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |
| 000564 (2020) |
Ruklanthi De Alwis [Singapour] ; Shiwei Chen [Singapour] ; Esther S. Gan [Singapour] ; Eng Eong Ooi [Singapour] | Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development |
| 000615 (2020) |
Chun Li [République populaire de Chine] ; Yanling Yang [République populaire de Chine] ; Linzhu Ren [République populaire de Chine] | Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species. |
| 000631 (2020) |
Katri Jalava [Finlande] | First respiratory transmitted food borne outbreak? |
| 000733 (2020) |
Cyril Chik-Yan Yip [République populaire de Chine] ; Chi-Chun Ho [République populaire de Chine] ; Jasper Fuk-Woo Chan [République populaire de Chine] ; Kelvin Kai-Wang To [République populaire de Chine] ; Helen Shuk-Ying Chan [République populaire de Chine] ; Sally Cheuk-Ying Wong [République populaire de Chine] ; Kit-Hang Leung [République populaire de Chine] ; Agnes Yim-Fong Fung [République populaire de Chine] ; Anthony Chin-Ki Ng [République populaire de Chine] ; Zijiao Zou [République populaire de Chine] ; Anthony Raymond Tam [République populaire de Chine] ; Tom Wai-Hin Chung [République populaire de Chine] ; Kwok-Hung Chan [République populaire de Chine] ; Ivan Fan-Ngai Hung [République populaire de Chine] ; Vincent Chi-Chung Cheng [République populaire de Chine] ; Owen Tak-Yin Tsang [République populaire de Chine] ; Stephen Kwok Wing Tsui [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine] | Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens. |
| 000884 (2020) |
Undurti N. Das [États-Unis] | Can Bioactive Lipids Inactivate Coronavirus (COVID-19)? |
| 000889 (2020) |
Kamal Kant Sahu [Oman] ; Ajay Kumar Mishra [Oman] ; Amos Lal [Oman] | COVID-2019: update on epidemiology, disease spread and management. |
| 000917 (2020) |
Toshiaki Kikuchi | COVID-19 outbreak: an elusive enemy☆ |
| 000937 (2020) |
John L. Frater [États-Unis] ; Gina Zini [Italie] ; Giuseppe D'Onofrio [Italie] ; Heesun J. Rogers [États-Unis] | COVID-19 and the clinical hematology laboratory. |
| 000971 (2020) |
Siu-Ying Lau [République populaire de Chine] ; Pui Wang [République populaire de Chine] ; Bobo Wing-Yee Mok [République populaire de Chine] ; Anna Jinxia Zhang [République populaire de Chine] ; Hin Chu [République populaire de Chine] ; Andrew Chak-Yiu Lee [République populaire de Chine] ; Shaofeng Deng [République populaire de Chine] ; Pin Chen [République populaire de Chine] ; Kwok-Hung Chan [République populaire de Chine] ; Wenjun Song [République populaire de Chine] ; Zhiwei Chen [République populaire de Chine] ; Kelvin Kai-Wang To [République populaire de Chine] ; Jasper Fuk-Woo Chan [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine] ; Honglin Chen [République populaire de Chine] | Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction. |
| 000977 (2020) |
Marco D'Arienzo [Italie] ; Angela Coniglio [Italie] | Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy |
| 000A83 (2019) |
Natacha S. Ogando [Pays-Bas] ; Francois Ferron [France, Allemagne] ; Etienne Decroly [France] ; Bruno Canard [France] ; Clara C. Posthuma [Pays-Bas] ; Eric J. Snijder [Pays-Bas] | The Curious Case of the Nidovirus Exoribonuclease: Its Role in RNA Synthesis and Replication Fidelity |
| 000A89 (2019) |
M. Alejandra Tortorici [États-Unis, France] ; David Veesler [États-Unis] | Structural insights into coronavirus entry |
